LIFEMD INC (LFMD) Fundamental Analysis & Valuation

NASDAQ:LFMD • US53216B1044

Current stock price

3.425 USD
-0.16 (-4.33%)
Last:

This LFMD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. LFMD Profitability Analysis

1.1 Basic Checks

  • In the past year LFMD has reported negative net income.
  • In the past year LFMD had a positive cash flow from operations.
  • In the past 5 years LFMD reported 4 times negative net income.
  • In multiple years LFMD reported negative operating cash flow during the last 5 years.
LFMD Yearly Net Income VS EBIT VS OCF VS FCFLFMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20M -40M -60M

1.2 Ratios

  • LFMD has a better Return On Assets (17.56%) than 97.14% of its industry peers.
  • LFMD has a Return On Equity of 53.38%. This is amongst the best in the industry. LFMD outperforms 100.00% of its industry peers.
Industry RankSector Rank
ROA 17.56%
ROE 53.38%
ROIC N/A
ROA(3y)-18.92%
ROA(5y)-73.98%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LFMD Yearly ROA, ROE, ROICLFMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -5K -10K -15K

1.3 Margins

  • LFMD has a Profit Margin of 5.26%. This is amongst the best in the industry. LFMD outperforms 88.57% of its industry peers.
  • With an excellent Gross Margin value of 87.44%, LFMD belongs to the best of the industry, outperforming 91.43% of the companies in the same industry.
  • In the last couple of years the Gross Margin of LFMD has grown nicely.
Industry RankSector Rank
OM N/A
PM (TTM) 5.26%
GM 87.44%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.53%
GM growth 5Y2.4%
LFMD Yearly Profit, Operating, Gross MarginsLFMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. LFMD Health Analysis

2.1 Basic Checks

  • LFMD does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for LFMD has been increased compared to 1 year ago.
  • The number of shares outstanding for LFMD has been increased compared to 5 years ago.
  • There is no outstanding debt for LFMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
LFMD Yearly Shares OutstandingLFMD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
LFMD Yearly Total Debt VS Total AssetsLFMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

  • Based on the Altman-Z score of 0.84, we must say that LFMD is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 0.84, LFMD perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
  • There is no outstanding debt for LFMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.84
ROIC/WACCN/A
WACC9.3%
LFMD Yearly LT Debt VS Equity VS FCFLFMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M

2.3 Liquidity

  • LFMD has a Current Ratio of 1.25. This is a normal value and indicates that LFMD is financially healthy and should not expect problems in meeting its short term obligations.
  • LFMD has a Current ratio of 1.25. This is in the lower half of the industry: LFMD underperforms 71.43% of its industry peers.
  • A Quick Ratio of 1.18 indicates that LFMD should not have too much problems paying its short term obligations.
  • The Quick ratio of LFMD (1.18) is worse than 71.43% of its industry peers.
Industry RankSector Rank
Current Ratio 1.25
Quick Ratio 1.18
LFMD Yearly Current Assets VS Current LiabilitesLFMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. LFMD Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 70.37% over the past year.
  • Looking at the last year, LFMD shows a quite strong growth in Revenue. The Revenue has grown by 10.59% in the last year.
  • LFMD shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 39.07% yearly.
EPS 1Y (TTM)70.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)10.59%
Revenue growth 3Y17.7%
Revenue growth 5Y39.07%
Sales Q2Q%-27.06%

3.2 Future

  • The Earnings Per Share is expected to grow by 23.26% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, LFMD will show a quite strong growth in Revenue. The Revenue will grow by 8.76% on average per year.
EPS Next Y60.16%
EPS Next 2Y85.61%
EPS Next 3Y23.26%
EPS Next 5YN/A
Revenue Next Year-3.96%
Revenue Next 2Y7.38%
Revenue Next 3Y8.76%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
LFMD Yearly Revenue VS EstimatesLFMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M
LFMD Yearly EPS VS EstimatesLFMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 -0.5 -1 -1.5 -2

More info and screens

Find the best growth stocksShow best growing peers

1

4. LFMD Valuation Analysis

4.1 Price/Earnings Ratio

  • LFMD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LFMD. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LFMD Price Earnings VS Forward Price EarningsLFMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40

4.2 Price Multiples

  • LFMD's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 179.43
LFMD Per share dataLFMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

  • A more expensive valuation may be justified as LFMD's earnings are expected to grow with 23.26% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y85.61%
EPS Next 3Y23.26%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. LFMD Dividend Analysis

5.1 Amount

  • LFMD does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

LFMD Fundamentals: All Metrics, Ratios and Statistics

LIFEMD INC

NASDAQ:LFMD (4/7/2026, 12:41:40 PM)

3.425

-0.16 (-4.33%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)03-09
Earnings (Next)05-04
Inst Owners39.57%
Inst Owner Change0%
Ins Owners17.81%
Ins Owner Change2.58%
Market Cap164.30M
Revenue(TTM)234.96M
Net Income(TTM)12.36M
Analysts82.86
Price Target9.95 (190.51%)
Short Float %15.95%
Short Ratio5.5
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.07
Dividend Growth(5Y)N/A
DP25.13%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-32.35%
Min EPS beat(2)-47.05%
Max EPS beat(2)-17.66%
EPS beat(4)1
Avg EPS beat(4)-145.36%
Min EPS beat(4)-635.29%
Max EPS beat(4)118.55%
EPS beat(8)2
Avg EPS beat(8)-75.65%
EPS beat(12)4
Avg EPS beat(12)-60.49%
EPS beat(16)5
Avg EPS beat(16)-55.17%
Revenue beat(2)0
Avg Revenue beat(2)-3.43%
Min Revenue beat(2)-4.95%
Max Revenue beat(2)-1.92%
Revenue beat(4)1
Avg Revenue beat(4)-2.99%
Min Revenue beat(4)-8.06%
Max Revenue beat(4)2.97%
Revenue beat(8)4
Avg Revenue beat(8)-0.03%
Revenue beat(12)7
Avg Revenue beat(12)1.1%
Revenue beat(16)7
Avg Revenue beat(16)-1.52%
PT rev (1m)5.41%
PT rev (3m)5.41%
EPS NQ rev (1m)-295.83%
EPS NQ rev (3m)-850%
EPS NY rev (1m)0%
EPS NY rev (3m)-208.7%
Revenue NQ rev (1m)-3%
Revenue NQ rev (3m)-3%
Revenue NY rev (1m)-1.4%
Revenue NY rev (3m)-1.4%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.7
P/FCF N/A
P/OCF 19.84
P/B 7.1
P/tB 13.37
EV/EBITDA 179.43
EPS(TTM)-0.16
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)0.17
OCFY5.04%
SpS4.9
BVpS0.48
TBVpS0.26
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 17.56%
ROE 53.38%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 5.26%
GM 87.44%
FCFM N/A
ROA(3y)-18.92%
ROA(5y)-73.98%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.53%
GM growth 5Y2.4%
F-Score6
Asset Turnover3.34
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 130.24%
Cap/Sales 4.05%
Interest Coverage N/A
Cash Conversion 1100.94%
Profit Quality N/A
Current Ratio 1.25
Quick Ratio 1.18
Altman-Z 0.84
F-Score6
WACC9.3%
ROIC/WACCN/A
Cap/Depr(3y)127.27%
Cap/Depr(5y)201.22%
Cap/Sales(3y)5.99%
Cap/Sales(5y)5.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)70.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y60.16%
EPS Next 2Y85.61%
EPS Next 3Y23.26%
EPS Next 5YN/A
Revenue 1Y (TTM)10.59%
Revenue growth 3Y17.7%
Revenue growth 5Y39.07%
Sales Q2Q%-27.06%
Revenue Next Year-3.96%
Revenue Next 2Y7.38%
Revenue Next 3Y8.76%
Revenue Next 5YN/A
EBIT growth 1Y59.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year637.05%
EBIT Next 3Y154.03%
EBIT Next 5YN/A
FCF growth 1Y-120.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-52.72%
OCF growth 3YN/A
OCF growth 5YN/A

LIFEMD INC / LFMD Fundamental Analysis FAQ

What is the ChartMill fundamental rating of LIFEMD INC (LFMD) stock?

ChartMill assigns a fundamental rating of 4 / 10 to LFMD.


Can you provide the valuation status for LIFEMD INC?

ChartMill assigns a valuation rating of 1 / 10 to LIFEMD INC (LFMD). This can be considered as Overvalued.


How profitable is LIFEMD INC (LFMD) stock?

LIFEMD INC (LFMD) has a profitability rating of 4 / 10.


Can you provide the financial health for LFMD stock?

The financial health rating of LIFEMD INC (LFMD) is 5 / 10.


What is the expected EPS growth for LIFEMD INC (LFMD) stock?

The Earnings per Share (EPS) of LIFEMD INC (LFMD) is expected to grow by 60.16% in the next year.